Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 13 Radiotherapy 12 Androgen Antagonists 12 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 pembrolizumab 8 toripalimab 7 darolutamide 7 Nivolumab 7 Drug Therapy 7 Docetaxel 7 Radiosurgery 6 Cystectomy 6 enzalutamide 5 apalutamide 5 abiraterone 5 Mitomycin 5 Cisplatin 5 Abiraterone Acetate 5 disitamab vedotin 4 Pluvicto 4 Cyclophosphamide 4 Axitinib 4 tislelizumab 3 fludarabine 3 enfortumab vedotin 3 cemiplimab 3 cabozantinib 3 Sunitinib 3 Standard of Care 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × PF06821497 × Genitourinary × Clear all

NCT07592910 2026-05-18

MOMENT

Prostate Cancer Clinical Trials Consortium

Phase 2 Not yet recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡